Human CX3C-chemokine/Fractalkine,FKN/CX3CL1 ELISA Kit

Contact us for 48 wells and bulk quote

Introducing the Human CX3C-chemokine/Fractalkine, FKN/CX3CL1 ELISA Kit, a cutting-edge solution designed to facilitate accurate and efficient detection of CX3C-chemokine/Fractalkine, also known as FKN/CX3CL1, in human samples. This ELISA kit is meticulously crafted to meet the highest standards of quality and reliability, ensuring precise and reproducible results.

The Human CX3C-chemokine/Fractalkine, FKN/CX3CL1 ELISA Kit employs a highly sensitive and specific enzyme-linked immunosorbent assay (ELISA) technique. By utilizing this advanced methodology, the kit enables researchers and clinicians to quantitatively measure the concentration of FKN/CX3CL1 in various biological samples, including serum, plasma, and cell culture supernatants.

This ELISA kit comprises all the necessary components, including pre-coated microplate wells, standards, controls, and reagents, meticulously optimized to ensure optimal performance. The assay procedure is straightforward, allowing for seamless integration into laboratory workflows. With a wide dynamic range and excellent sensitivity, this kit offers unparalleled precision and accuracy in FKN/CX3CL1 quantification.

The Human CX3C-chemokine/Fractalkine, FKN/CX3CL1 ELISA Kit is an indispensable tool for researchers and clinicians involved in the study of chemokines and their role in various physiological and pathological processes. It provides a comprehensive and reliable platform for investigating the potential involvement of FKN/CX3CL1 in inflammation, immune response, neurodegenerative diseases, and cancer.

In summary, the Human CX3C-chemokine/Fractalkine, FKN/CX3CL1 ELISA Kit offers a state-of-the-art solution for the accurate and efficient detection of FKN/CX3CL1 in human samples. With its exceptional sensitivity, precision, and ease of use, this kit empowers researchers and clinicians to unravel the intricate mechanisms underlying chemokine-mediated processes, ultimately contributing to advancements in biomedical research and clinical diagnostics.